openPR Logo
Press release

Drug Discovery Services Market - Qualitative Opportunities 2025 | Thermo Fisher Scientific, Charles River Laboratories International, Albany Molecular Research Inc., Domainex

06-06-2019 12:00 PM CET | Health & Medicine

Press release from: TMR Research

TMR Research

TMR Research

Global Drug Discovery Services Market: Snapshot

The global drug discovery services market is thriving on account of the rising impetus given to research and development across several industrial. Drug discovery forms an important niche of the pharmaceutical industry, and the extensive efforts employed by researchers to invent new drug models have popularized the market. The pharmaceutical companies have become increasingly concerned about manufacturing novel drugs, and freeing the process of drug discovery from any hassles. Hence, outsourcing of drug discovery has emerged as a prominent trend amongst these companies, which has propelled demand within the market. Furthermore, the rising expenditure on research and development of new drugs for the treatment of fatal diseases and disorders has also pushed market growth. Clinical trials and analytic testing is an important standpoint to analyze the contributors to the market. One of the most pressing concerns within the medical circles is the rising instance of cancers across the globe. Scientists and researchers are undertaking key research, testing, and development initiatives in order to find permanent cures for different cancers. Hence, the market for drug discovery services is treading a positive growth path on account of the developments in oncology.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2696

The geographical segmentation of the market reveals key segments viz. North America, Europe, Asia Pacific, Latin America, and the rest of the world. The prominence of the North American region in research and development is expected to bolster regional growth.

WuXi AppTec, Albany Molecular Research Inc., GenScript, Charles River Laboratories International, Covance, and Evotec are some of the key players with proven competency within the market. These market players are expected to engage in core research in order to come up with effective drugs and molecular compositions.

Global Drug Discovery Services Market: Overview

The key factors boosting the drug discovery services market is the increasing research and development expenditure, an increase in the number of pharmaceutical companies outsourcing their work to avoid various hassles, and an increasing demand for outsourcing clinical trials services and analytical testing. However, the market can be restricted on account of the stringent regulations which govern drug discovery. Stringent policies regarding the use of animals will also hamper the growth of this market. In addition to this the high cost involved in the discovery and development of drugs will pose a challenge for the growth of this market.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=2696

Global Drug Discovery Services Market: Trends

Of the two types of drugs available in the market viz biologics and small molecules, the demand for small molecules is large on account of the simplicity of these drugs as well as the ease to characterize. As small molecules are well defined, they can easily enter cells, cause a person's cancer cells to die, and affect other molecules. Thus, many targeted therapies make use of small molecules. Of the key services offered such as biology service, medicinal chemistry, and drug metabolism and pharmacokinetics (DMPK), the demand for medicinal chemistry is high on account of the growing inclination of pharmaceutical companies towards outsourcing. On the basis of therapeutic area, this market may be categorised into neurology, oncology, respiratory diseases, cardiovascular diseases, and diabetes. Of these it is estimated that the oncology therapeutic area will drive maximum revenue on account of the increasing number of patients suffering from cancer.

Global Drug Discovery Services Market: Market Potential

Target selection, hit to lead identification, target validation, candidate validation, and lead optimisation are some of the processes in the drug discovery service market. Of these, the hit to lead identification process is emerging as a leading process on account of the growing research based on high throughput screening.

Global Drug Discovery Services Market: Regional Outlook

The global drug discovery services market can be segmented into Europe, North America, Latin America, Asia Pacific, and the Rest of the World. Of these, it is anticipated that North America will continue to lead in the market on account of the early adoption of advanced technologies. Asia Pacific is also expected to emerge as a key drug discovery services market in the years to come.

Global Drug Discovery Services Market: Competitive Landscape:

The market for drug discovery services is highly fragmented with a large number of regional and international players. Some of the players are: Thermo Fisher Scientific, Charles River Laboratories International, Albany Molecular Research Inc., Domainex, WuXi AppTec, Piramal Enterprises, GenScript, GVK Biosciences, Jubilant Biosys, Pharmaceutical Product Development, LLC (PPD), Merck, SRI International, Covance, Viva Biotech, Evotec, Selcia Limited, GE Healthcare, and Lonza.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Services Market - Qualitative Opportunities 2025 | Thermo Fisher Scientific, Charles River Laboratories International, Albany Molecular Research Inc., Domainex here

News-ID: 1766487 • Views:

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug